Skip to content
Graphic of a grey and white triangle
Graphic of a grey and white triangle

Commercial Intellectual Property

Allen & Overy’s commercial intellectual property team advises clients on the full range of commercial contracts relating to the exploitation of IP rights.

With the ever-growing focus on innovation, protecting and leveraging IP assets is crucial. A&O’s commercial IP lawyers work closely with our M&A and antitrust colleagues to provide coordinated advice on the full range of IP-rich transactions.

We advise on complex cross-border collaborations, joint ventures and strategic licensing deals involving parties all over the world.

Our experience spans the most complex transactions and includes:

  • Licensing, joint ventures and collaborations
  • Sales and other forms of disposal of IP rights, including warranty protection
  • IP due diligence and verification, including related agreements
  • Antitrust risks in licensing, joint venture and non-compete arrangements, including related to the settlement of patent disputes
  • Procedures and negotiations of arrangements for parties seeking to exit, or in the event of insolvency or bankruptcy of one party
  • Distribution, agency, contract manufacture, supply, sponsorship and other commercial agreements
  • IP-backed asset financing and taking security interests over IP assets, including royalty monetisation agreements

Our experience

Marks & Spencer

Marks & Spencer

on the IP aspects of its GBP750m food delivery joint venture with Ocado, the UK’s leading pure play digital grocer.

Exscientia Limited

Exscientia Limited

on a research collaboration and licence agreement with Roche pursuant to which Exscientia will use its AI drug discovery platform to design pre-clinical drug candidates for Roche.

Colfax Corporation

Colfax Corporation

on the complex division and transfer of an existing trade mark portfolio, including WIPO and other foreign trade marks, in connection with its USD57m acquisition of ČKD Kompresory, based in Prague, Czech Republic, from ČKD Group.

Celyad

Celyad

on a licence agreement concerning several of its pharmaceutical cancer products with ONO, for several Asian territories.

News & insights

Birdseye view of person crossing road

Publications: 11 DECEMBER 2020

Grey area gains ground

Adrian Dykes fills us in on why the idea of descriptiveness was not quite black and white. T-133/19, Off-White LLC v EUIPO, General Court, 25th June 2020.

Read more
How EasyMile is tackling the under-30mph market and the impact of the pandemic on the autonomous vehicle industry

Publications: 10 DECEMBER 2020

Podcast: An update on Singapore’s efforts to develop a legal frame-work for self-driving vehicles

In the latest installment of Propel, our podcast series on autonomous vehicles, New York partner Paul Keller interviews Siyuan Chen, Associate Professor at Singapore Management University, Simon…

Read more
How EasyMile is tackling the under-30mph market and the impact of the pandemic on the autonomous vehicle industry

Publications: 19 NOVEMBER 2020

Podcast: A discussion with Zenzic, the coordinator of the UK’s efforts to develop advanced mobility services

In the latest installment of Propel, our podcast series on self-driving vehicles, Paul Keller interviews Daniel Ruiz, CEO of Zenzic, the UK agency leading the coordination of that country’s testing…

Read more
Allen & Overy graphic

Publications: 14 JULY 2020

Webinar: Beyond Covid-19: Implications for intellectual property

In the second and final webinar in our series, our IP team discusses the future global impact of Covid-19 coronavirus on IP from a transactional, litigation and regulatory perspective.

Read more

Recognition of our work

Related content